{{Rsnum
|rsid=11624704
|Gene=NRXN3
|Chromosome=14
|position=78319734
|Orientation=plus
|GMAF=0.1148
|Gene_s=NRXN3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 75.2 | 22.1 | 2.7
| HCB | 91.2 | 8.8 | 0.0
| JPT | 77.9 | 22.1 | 0.0
| YRI | 76.2 | 21.8 | 2.0
| ASW | 73.7 | 26.3 | 0.0
| CHB | 91.2 | 8.8 | 0.0
| CHD | 88.1 | 11.9 | 0.0
| GIH | 78.2 | 17.8 | 4.0
| LWK | 86.4 | 12.7 | 0.9
| MEX | 72.4 | 22.4 | 5.2
| MKK | 70.5 | 28.2 | 1.3
| TSI | 65.7 | 34.3 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21552555
|Trait=None
|Title=A genome-wide association study on obesity and obesity-related traits.
|RiskAllele=
|Pval=3E-9
|OR=None
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=21676558
|Title=Associations among types of impulsivity, substance use problems and neurexin-3 polymorphisms.
|OA=1
}}

{{PMID Auto
|PMID=23306218
|Title=Association study of NRXN3 polymorphisms with schizophrenia and risperidone-induced bodyweight gain in Chinese Han population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}